Press Releases

ASX Announcement

By |2021-05-26T04:08:40+00:00May 24th, 2021|

Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial

Download PDF

Shareholder newsletter

By |2021-05-18T07:04:35+00:00May 18th, 2021|

May 2021 newsletter

Download PDF

ASX Announcement

By |2021-05-18T00:17:23+00:00May 3rd, 2021|

CLTX CAR T Abstract Accepted for Presentation at ASCO

Download PDF

ASX Announcement

By |2021-04-25T22:27:05+00:00April 23rd, 2021|

Appendix 4C – quarterly

Download PDF

ASX Announcement

By |2021-04-21T23:31:36+00:00April 21st, 2021|

Successful Completion of First Patient Cohort Phase 1 Trial

Download PDF

ASX Announcement

By |2021-03-17T23:50:50+00:00March 17th, 2021|

Successful Completion of Dosing in First Patient Cohort

Download PDF

ASX Announcement

By |2021-02-24T01:21:57+00:00February 24th, 2021|

Dr Eliot Bourk, Former Kite Pharma Senior Executive, Joins Chimeric as VP Business & Corporate Development

Download PDF

Shareholder newsletter

By |2021-02-08T01:19:46+00:00February 8th, 2021|

January 2021 newsletter

Download PDF

ASX Announcement

By |2021-02-01T02:18:14+00:00February 1st, 2021|

Former Juno Executive Cindy Elkins Joins Chimeric Board

Download PDF

ASX Announcement

By |2021-01-18T04:54:04+00:00January 18th, 2021|

Chimeric Therapeutics Commences Trading on the ASX

Download PDF